Moderna News: MRNA Stock Soars 11% on Covid-19 Vaccine Phase 2 Trial

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

Moderna (MRNA) news for Thursday concerning a Phase 2 trial of its vaccine to treat the novel coronavirus has MRNA stock heading higher.

The post Moderna News: MRNA Stock Soars 11% on Covid-19 Vaccine Phase 2 Trial appeared first on InvestorPlace.

• America’s #1 Stock Picker Reveals Next 1,000% Winner
• 25 Stocks You Should Sell Immediately
• #1 Under-the-Radar 5G Stock to Buy Now
• The 1 Stock All Retirees Must Own